Skip to main content

Peer Review reports

From: Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507)

Original Submission
2 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Jul 2023 Reviewed Reviewer Report
24 Sep 2023 Reviewed Reviewer Report
24 Oct 2023 Author responded Author comments - Jake Tempo
Resubmission - Version 3
24 Oct 2023 Submitted Manuscript version 3
25 Oct 2023 Author responded Author comments - Jake Tempo
Resubmission - Version 4
25 Oct 2023 Submitted Manuscript version 4
Publishing
26 Oct 2023 Editorially accepted
24 Nov 2023 Article published 10.1186/s12894-023-01352-0

You can find further information about peer review here.

Back to article page